C12 NBD Globotriaosylceramide structure
|
Common Name | C12 NBD Globotriaosylceramide | ||
|---|---|---|---|---|
| CAS Number | 2692623-26-8 | Molecular Weight | 1146.32 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C54H91N5O21 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of C12 NBD GlobotriaosylceramideC12 NBD galactosylceramide is a biologically active derivative of galactosylceramide that is tagged with a fluorescent C12 nitrobenzoxadiazole (C12 NBD) group. C12 NBD galactosylceramide has been used to detect ceramide trihexoside[1]. |
| Name | C12 NBD Globotriaosylceramide |
|---|
| Description | C12 NBD galactosylceramide is a biologically active derivative of galactosylceramide that is tagged with a fluorescent C12 nitrobenzoxadiazole (C12 NBD) group. C12 NBD galactosylceramide has been used to detect ceramide trihexoside[1]. |
|---|---|
| Related Catalog | |
| In Vitro | C12 NBD globotriaosylceramide accumulates in human umbilical vascular endothelial cells (HUVECs) treated with the α-galactosidase A inhibitor in a concentration-dependent manner[2]. |
| References |
| Molecular Formula | C54H91N5O21 |
|---|---|
| Molecular Weight | 1146.32 |